Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | BTK | Q06187 | 5/20 | 0.45 |
| ▸ | DRD2 | P14416 | 5/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27982972 | 0.91 | KDM1A (0.44) | KDM1AMAOBBTKDRD2NFKB1 | |
| SCHEMBL31206020 | 0.88 | RAB9A (0.48) | KDM1AMAOBBTKDRD2EPHX2 | |
| SCHEMBL25042395 | 0.84 | KDM1A (0.45) | KDM1AMAOBBTKDRD2EPHX2 | |
| SCHEMBL31205821 | 0.83 | KDM1A (0.44) | KDM1AMAOBBTKDRD2EPHX2 | |
| SCHEMBL25042393 | 0.83 | KDM1A (0.44) | KDM1AMAOBBTKDRD2EPHX2 | |
| SCHEMBL31206132 | 0.83 | ACACB (0.47) | DRD2KMT2A | |
| SCHEMBL29665851 | 0.82 | KDM1A (0.44) | KDM1AMAOBBTKDRD2EPHX2 | |
| SCHEMBL24512915 | 0.82 | KDM1A (0.44) | KDM1AMAOBBTKDRD2EPHX2 | |
| SCHEMBL31206247 | 0.82 | KDM1A (0.46) | KDM1AMAOBBTKDRD2NFKB1 | |
| SCHEMBL25042392 | 0.81 | KDM1A (0.45) | KDM1AMAOBBTKDRD2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240360114-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240360114-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | AIFM2, GPX1, GPX4 | KDM1A 3776/4885MAOB 1677/4885BTK 3650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.